Genmab — December 2019
-
Det er ok nsrafk. Vores kultur er anderledes end mange er vant til fra andre platforme.
-
Bryan Garnier hæver fair value til 1600 fra 1550 og gentager Buy
-
Angående Mim-8 er der også to andre præsentationer, hvis du ikke allerede har set dem. https://ash.confex.com/ash/2019/webprogram/Paper123340.html og https://ash.confex.com/ash/2019/webprogram/Paper128159.html har ikke en pind forstand på det, men det virker særdeles gennemarbejdet på dette tidlige trin
-
og det havde effekt på alle 3 patienter
-
ALCYONE JNJ press release & Lancet article https://www.companynewshq.com/company-news/pharmaceutical-company-news/darzalex-daratumumab-shows-overall-survival-benefit-and-continued-improvement-in-progression-free-survival-in-patients-with-newly-diagnosed-multiple-myeloma-who-are-ineligible-for-transplant/ https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32956-3/fulltext
-
ASH 2019: Dr. Kevin Song on the Bortezomib and dexamethasone +/- daratumumab in first relapse patients with multiple myeloma: Update of the CASTOR trial https://www.youtube.com/watch?v=gP1ROj5j4jk
-
Forventer vi os noget stort af LB senere i dag?
-
CANDOR blev omtalt overordentlig positivt af adskillige KOLs på Twitter i går.
-
-
-
Bluebird stiger på bb21217 https://seekingalpha.com/news/3525157-bluebird-bio-up-3-on-updated-car-t-candidate-bb21217-data
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind